Within a single week, two major players in the drug discovery instrumentation and reagent industry—Thermo Electron and Invitrogen—made moves to capitalize on the ever-strengthening Chinese biotechnology and pharmaceutical markets, further entrenching the
The Biotechnology Greenhouse of Southeastern Pennsylvania BioAdvance recently announced the selection of Dr. Michael Pellini as the organization’s inaugural Entrepreneur-in-Residence. Part of a $2-billion initiative by the Commonwealth of Pennsylvania to
In late 2004, Bookham New Focus introduced the Clarity line of fluorescence filters, developed for use in analytical and diagnostic instruments, including fluorescence microscopy, flow cytometry, DNA sequencing, microarrays, and other fluorescence applica
The lab-on-a-chip (LOC) field may be about to hit its stride with the recent introduction of a fully automated system by Agilent Technologies. Designed to replace gel electrophoresis steps, the Agilent 5100 ALP allows researchers to perform thousands of u
Health science heavyweight PerkinElmer and proteomics technology developer Procognia announced in mid-December a co-marketing agreement that combines PE’s Protein Array Workstation and ProScan Array HT with Procognia’s U-c lectin array-based platform to c
In a move that further broadens its offerings in bioinformatics software, Tripos Inc. closed its acquisition earlier this month for Austin, Texas-based Optive Research, a two-year old technology and software spinout of the University of Texas at Austin.
With $100 million in its coffers, Amgen Ventures, a corporate venture capital fund initiated by Amgen Inc. in late 2004, will provide monetary assistance for emerging biotechnology companies that work in Amgen’s areas of interest related to human therapeu
After several months of discussions, GenoLogics Life Sciences Software Inc., based here, and Nonlinear Dynamics of Newcastle upon Tyne, England, have entered into a global partnership agreement that will result in an integrated protein informatics softwar
Ricerca Biosciences LLC in December completed a capacity expansion of its in vivo pre-clinical testing capability and was also in the process of a similar expansion in its medicinal chemistry and chemical development services. The additional capacity was
Somewhat lost among the rising cheers of public and private research institutions after the passage of California Proposition 71, a measure that will provide nearly $3 billion in public funding in the state for stem cell research over the next 10 years, w
Novasite Pharmaceuticals Inc. announced it has received a four-year grant valued at nearly $3.4 million for continued development of its proprietary parallel screening technology for G-Protein Coupled Receptors (GPCRs).
With the recent launch of the multidisciplinary Metrology for Gene Expression Program, the National Institute of Standards and Technology (NIST) is hoping to explore and address the challenges associated with the measurement, validation, and quality contr
Pall Corp. in late 2004 finalized the $32-million purchase of Ciphergen Biosystems Inc.’s process chromatography sorbent business. The acquisition of the BioSepra Process Division fills a crucial “missing link” in Pall’s extensive fluid management offerin
Geron Corp. in January announced a worldwide license agreement with Cambrex Bio Science Walkersville Inc. under which the Cambrex subsidiary will develop and distribute cell lines that have been immortalized using Geron’s proprietary telomerase technology